Next Article in Journal
Optimal Use of Vaccines for Control of Influenza A Virus in Swine
Previous Article in Journal
CD137 Enhancement of HPV Positive Head and Neck Squamous Cell Carcinoma Tumor Clearance
Previous Article in Special Issue
Tumor-Associated Glycans and Immune Surveillance
 
 
Article

The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration

1
International AIDS Vaccine Initiative, 125 Broad St., 9th Floor, New York, NY 10004, USA
2
Chinese National Center for AIDS/STD Control and Prevention (NCAIDS), Beijing 102206, China
3
Futures Institute, Glastonbury, CT 06033, USA
4
Columbia University Global Centers, East Asia, Beijing 100080, China
5
PATH, Seattle, WA 98121, USA
6
Center for Disease Control and Prevention of Sichuan Province, Chengdu 610041, China
7
Joint United Nations Programme for HIV/AIDS (UNAIDS), Geneva CH-1211, Switzerland
*
Author to whom correspondence should be addressed.
Academic Editor: Diane M. Harper
Vaccines 2015, 3(1), 1-19; https://doi.org/10.3390/vaccines3010001
Received: 15 October 2014 / Accepted: 19 November 2014 / Published: 5 January 2015
(This article belongs to the Special Issue Feature Papers)
China’s commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response. This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection. A preventive HIV vaccine would add a powerful tool to China’s response, even if not 100% efficacious or available to the full population. View Full-Text
Keywords: HIV/AIDS; vaccines; China; Sichuan; prevention; research; modeling HIV/AIDS; vaccines; China; Sichuan; prevention; research; modeling
Show Figures

Figure 1

MDPI and ACS Style

Harmon, T.; Guo, W.; Stover, J.; Wu, Z.; Kaufman, J.; Schneider, K.; Liu, L.; Feng, L.; Schwartländer, B. The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration. Vaccines 2015, 3, 1-19. https://doi.org/10.3390/vaccines3010001

AMA Style

Harmon T, Guo W, Stover J, Wu Z, Kaufman J, Schneider K, Liu L, Feng L, Schwartländer B. The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration. Vaccines. 2015; 3(1):1-19. https://doi.org/10.3390/vaccines3010001

Chicago/Turabian Style

Harmon, Thomas, Wei Guo, John Stover, Zunyou Wu, Joan Kaufman, Kammerle Schneider, Li Liu, Liao Feng, and Bernard Schwartländer. 2015. "The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration" Vaccines 3, no. 1: 1-19. https://doi.org/10.3390/vaccines3010001

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop